Diabetes Trials Unit

Home page

The Diabetes Trials Unit (DTU), founded in 1985 by Professor Rury Holman, specialises in performing diabetes-related national and multinational mega trials in partnership with the NHS, NIH, MRC, BHF, DUK, academic institutions and industry. The DTU also undertakes major modelling and statistical programmes to utilise fully the data available from its many studies, with a particular emphasis on modelling diabetes and cardiovascular disease processes. Current studies include 4-T, ACE, TECOS and EXSCEL.

DTU trials, which are all conducted to Good Clinical Practice (GCP) standards, range from proof of concept and efficacy studies (Phase IIA/B) to Phase III and Phase IV randomised multi-centre and international controlled trials. The DTU is a fully registered UKCRC Clinical Trials Unit It is a founder member of the Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM), a part of the RAE2008 4* rated University of Oxford Nuffield Department of Medicine and a founder member of the Oxford Comprehensive Biomedical Research Centre, funded by the UK National Institute for Health Research (NIHR). [Less...].

News

Show all

2013	May	TRG Research Bulletin 10 - 2013
	March	The Global Reach of TECOS